Mylaxen; intensification of neuromuscular blocking effect by combination with succinylcholine.
D005449:Fluorenes; D006584:Hexamethonium Compounds; D006801:Humans; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D009465:Neuromuscular Agents; D013390:Succinylcholine / Q000494:pharmacology*
D005449:Fluorenes; D006584:Hexamethonium Compounds; D009125:Muscle Relaxants, Central; D009465:Neuromuscular Agents; C005034:hexafluorenium; D013390:Succinylcholine
MUSCLE RELAXANTS/therapeutic use; SUCCINYLCHOLINE/effects